➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
Merck
Boehringer Ingelheim
Moodys

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Alkem Labs Ltd Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ALKEM LABS LTD, and what generic and branded alternatives to ALKEM LABS LTD drugs are available?

ALKEM LABS LTD has sixty-five approved drugs.

There are twelve tentative approvals on ALKEM LABS LTD drugs.

Summary for Alkem Labs Ltd
US Patents:0
Tradenames:54
Ingredients:54
NDAs:65

Drugs and US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd ARIPIPRAZOLE aripiprazole TABLET;ORAL 207105-004 Feb 21, 2019 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 200737-004 Dec 7, 2012 AA RX No No   Start Trial   Start Trial
Alkem Labs Ltd DABIGATRAN ETEXILATE MESYLATE dabigatran etexilate mesylate CAPSULE;ORAL 208040-002 Mar 11, 2020 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 204453-002 Sep 28, 2016 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 203269-002 Feb 18, 2016 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065496-002 Jun 7, 2010 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 6,703,418   Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 6,703,418   Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 6,703,418   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
Boehringer Ingelheim
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.